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632Objective: The aim of our study was to evaluate the long-term outcome of patients exclusively undergoing total
arterial revascularization off-pump coronary artery bypass grafting and to compare the performance of the radial
artery and the right internal thoracic artery as a second conduit.
Methods:We studied a consecutive series of 1700 patients undergoing off-pump coronary artery bypass graft-
ing, receiving a radial artery or right internal thoracic artery as a second graft for total arterial revascularization,
between 2003 and 2010. A total of 1447 patients (85.11%) received bilateral internal thoracic artery grafting,
and 253 patients (14.89%) received left internal thoracic artery and radial artery grafting. A propensity score–
matched analysis was performed to compare the 2 groups, bilateral internal thoracic artery and left internal
thoracic artery and radial artery, relative to overall survival, morbidity, and combined end points event–free
survival. Hazard ratios (HRs) and their 95% confidence intervals (CIs) were estimated by Cox regression.
Results: In the full unmatched patient population, the postoperative survival (HR, 0.59; 95% CI, 0.38-0.92;
P ¼ .021), incidence of reintervention/readmission (HR, 0.42; 95% CI, 0.28-0.61; P<.001), and combined
end points (HR, 0.47; 95% CI, 0.35-0.63; P<.001) were significantly better in the bilateral internal thoracic
artery group. In the propensity score–matched patient population, the incidence of reintervention/readmission
(HR, 0.40; 95% CI, 0.18-0.88; P ¼ .02) and combined end points (HR, 0.54; 95% CI, 0.32-0.92; P ¼ .02)
were significantly better in the bilateral internal thoracic artery group compared with the left internal thoracic
artery–radial artery group.
Conclusions: The results of our study provide evidence for the superiority of the right internal thoracic artery
graft compared with the radial artery as a second conduit in total arterial revascularization off-pump coronary
artery bypass grafting. (J Thorac Cardiovasc Surg 2014;147:632-8)The beneficial effects after coronary artery bypass are di-
rectly related to the patency of the coronary grafts, but
they also may be multifactorial. Use of bilateral internal
thoracic artery (BITA) grafting rather than unilateral inter-
nal thoracic artery (ITA) grafting has been associated with
increased survival and fewer cardiac events.1 In an attempt
to maximize the use of arterial conduits on the presumption
that these might yield a better outcome than vein grafts, ar-
terial conduits such as the right internal thoracic artery
(RITA) and the radial artery (RA) have been considered
to be the logical step forward to revascularize the non–left
anterior descending (LAD) coronary system. Clinical stud-
ies have documented equivalent long-term benefits withe Cardiac Surgery Service, Instituto Cardiovascular de Buenos Aires, Argen-
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The Journal of Thoracic and Cardiovascular SurgRITA grafting to the left coronary system or the right coro-
nary system with superior survival and lower need for fur-
ther redo coronary artery bypass grafting (CABG).2-4
However, outcome studies investigating the RA as a sec-
ond arterial bypass conduit show conflicting results. A ret-
rospective angiographic study by Khot and colleagues5
demonstrated a significantly lower patency rate for the
RA compared with ITA or even saphenous vein grafts
(SVGs). In a prospective randomized clinical trial, Gold-
man and colleagues6 recently showed that the RA was not
superior to the SVG relative to 1-year patency. However,
Hayward and colleagues7 demonstrated that comparable
angiographic and clinical outcomes can be achieved with
any free arterial graft to the largest non-LAD target.
The aim of our analysis was to evaluate the long-term
outcome of patients exclusively undergoing total arterial re-
vascularization (TAR) off-pump coronary artery bypass
(OPCAB), comparing the performance of the RA and the
RITA as the second arterial graft.MATERIALS AND METHODS
This is a retrospective analysis of prospectively gathered data over an
8-year period of all patients undergoing OPCAB at the Instituteery c February 2014
Abbreviations and Acronyms
BITA ¼ bilateral internal thoracic artery
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
euroSCORE ¼ European System for Cardiac
Operative Risk Evaluation
HR ¼ hazard ratio
IQR ¼ interquartile range
ITA ¼ internal thoracic artery
LAD ¼ left anterior descending
LITA ¼ left internal thoracic artery
OPCAB ¼ off-pump coronary artery bypass
OR ¼ odds ratio
RA ¼ radial artery
RITA ¼ right internal thoracic artery
SVG ¼ saphenous vein graft
TAR ¼ total arterial revascularization
Navia et al Acquired Cardiovascular Disease
A
C
DCardiovascular of Buenos Aires and who received TAR with left internal
thoracic artery (LITA) grafting and a RITA or RA bypass as a second arte-
rial conduit. From January 2003 to May 2011, a total of 1700 consecutive
patients (of 1894) were scheduled for urgent or elective procedure under-
going TAROPCAB and fulfilled the inclusion criteria of our observational
study. A total of 1447 patients (85.11%) received BITA grafting, and 253
patients (14.89%) received LITA-RA grafting. All patient data were pro-
spectively collected by using our custom-made database (Microsoft Ac-
cess; Microsoft Corp, Redmond, Wash), which is used daily for clinical
data management. Preoperative, operative, and postoperative data were ob-
tained by retrospective review of clinical and pathology reports from the
database and crosschecked with all medical charts. Two-dimensional bi-
plane echocardiogram was used for left ventricular function evaluation.
Moderate/severe left ventricular function was defined following Simpson’s
rule (ejection fraction<35%). Postoperative complications were defined as
follows: myocardial infarction (new Q-wave or loss of R-wave progression
across the chest leads or creatine kinase myocardial band enzyme>10%),
low cardiac output (a newly placed intra-aortic balloon pump or use of ino-
tropic drugs for>48 hours), bleeding requiring a rethoracotomy, mechan-
ical ventilatory support more than 48 hours, or renal failure (creatinine>2
mg/dL or 100% increase of the preoperative value, with or without the need
of dialysis). Strokewas defined as a central neurologic deficit persisting for
more than 24 hours or confirmed by computed tomography. Deep sternal
wound infection was defined according to the evidence of mediastinitis
during sternal reexploration. Operations in all the patients in this group
were performed with the intention of carrying out the OPCAB (intention
to treat), and the criteria used for conversion to on-pump CABG were he-
modynamic or electric instability and calcified or intramyocardial coronary
arteries.
Completeness of arterial revascularization was attempted in all cases
and defined as all diseased coronary systems (stenosis>70%) receiving
at least 1 arterial graft insertion. This relationship (graft insertion/lesion
>70%) was evaluated for the LAD, circumflex artery, and right coronary
artery systems in all patients. Hospital mortality and incidence of major
complications (hospital mortality, myocardial infarction, renal failure,
and stroke) were analyzed in both groups. Multivariate analysis was per-
formed to identify independent predictors for the incidence of hospital
mortality and major complications.
Late events were achieved by direct communication with the patient,
their family, and attending physician, and medical records were revised.The Journal of Thoracic and CaThe interview investigated the survival, the symptoms, the long-term med-
ical management, the incidence of hospital readmissions or need for rein-
tervention (percutaneous coronary intervention and redo CABG), and any
operations-related complications. Data collected for readmissions included
recurrent angina, new acute myocardial infarction, and congestive heart
failure. A combined end points–free survival period at follow-up (mortality
plus readmission/reintervention) alsowas considered. The institutional eth-
ical committee approved the trial, and surgical consent was obtained from
each patient with respect to surgical method and postoperative evaluations.
Surgical Technique
The surgical technique used for the OPCAB procedure has been re-
ported8 and consists of using both internal thoracic arteries (LITA-RITA)
as exclusive conduits for coronary revascularization in the BITA group.
Most ITA grafts were harvested in a skeletonized fashion, and the most
commonly used technical configuration used was in situ anastomoses of
the LITA to the LAD, and the RITA, after being divided at its origin, was
connected end to side to the in situ LITA as a sequential T graft to the cir-
cumflex and right coronary arteries. In the LITA-RA group, the RA re-
placed the RITA graft and was also used as a sequential T graft from the
LITA to the circumflex artery and the right coronary system. All sequential
anastomosis were created as a diamond-shaped configuration. All RAs
were harvested using an open surgical technique, and intraluminal irriga-
tion with heparin and papaverine solution was used. No vein grafts or prox-
imal anastomoses in the aorta were carried out in any of these patients.
Propensity Score Matching and Statistical Analysis
Propensity score matching was used to reduce the impact of treatment
selection in comparing RA and RITA as the second conduit for TAR. Pre-
operative characteristics of patients in these study groups were summarized
as mean  standard deviation, median and interquartile range (IQR), or
prevalence (in percentage) as appropriate. Student t test for independent
sample or Mann–Whitney U test for continuous variables and chi-square
tests for categoric variables were applied to examine differences between
the BITA and LITA þ RA groups. Variables revealing a P value less
than .2 in this analysis were entered into a logistic regression analysis
with the use of the RA versus the RITA as the dependent variable. This
was performed to generate a propensity score for each patient representing
the probability to receive a RITA or RA as described by Puskas and col-
leagues9 and Emmert and colleagues.10
In our OPCAB experience, LITA-RA represents an earlier experience
and BITA grafting came later. Because the operative eras were different,
the date of surgery was incorporated into the propensity score. We divided
the entire time frame of the study into quartiles, each including one quarter
of the observations, and this parameter was one of the variables used to
build the propensity score. The observations were then matched by propen-
sity score within each quartile to ensure perfect matching time between
cases with one or another type of surgery technique. The 4 considered
time quartiles were (1) January 8, 2003, to March 25, 2005; (2) March
26, 2005, to November 28, 2006; (3) November 29, 2006, to December
29, 2008; and (4) December 30, 2008, to May 31, 2011. Five-digit match-
ing without replacement was applied to form the matched sample. For each
patient receiving BITA, 1 patient receiving LITA þ RAwas randomly se-
lected in a 1:1 manner in case of an agreement of the propensity score
(2 digits behind comma). The balance of measured variables between the
study groups in the matched sample was assessed using a paired t test or
Wilcoxon test for continuous measures and the McNemar test for categoric
measures. Kaplan–Meier analysis, together with log-rank testing, was used
to evaluate the postoperative survival, readmission/reintervention, and
combined end points–free survival in the full unmatched patient popula-
tion. Finally, a Cox proportional hazards regression model was used to
estimate the treatment effect and its statistical significance relative to
cumulative survival, readmission/reintervention, and combined end
points–free survival between the BITA and LITA þ RA groups.rdiovascular Surgery c Volume 147, Number 2 633
TABLE 1. Preoperative characteristics of full unmatched patient
population undergoing total arterial revascularization
BITA
(n ¼ 1447)
LITA-RA
(n ¼ 253) P value
Age (y) 63.3  9 68.5  10 <.0001
Male gender (%) 91.5 77.5 <.0001
Diabetes (%) 25.6 33.4 .004
HTA (%) 77.9 80 .2
Severe LVF (%) 19.7 35 .0001
Previous MI (%) 29.3 30 .7
Previous PCI (%) 22.5 23.1 .4
Previous CABG (%) 0.5 3.1 <.001
Previous class IV (NYHA) (%) 2.1 6.7 <.0001
Previous stroke (%) 3.5 3.5 .5
Aortic calcification (%) 2.2 5.5 .006
euroSCORE (mean) 2.7  2.3 4.8  3.3 .0001
Previous renal disease (%) 4.2 6.3 .2
Previous IABP (%) 1.7 4.3 .01
Nonelective surgery (%) 33.5 46.6 .0001
Taking aspirin preoperatively (%) 78.8 45.9 .0001
Taking clopidogrel preoperatively (%) 12.2 14.6 .3
2-vessel disease (%) 18.2 21
3-vessel disease (%) 81.7 79 .1
Left main disease (%) 22.3 26.1 .1
No. of target vessels/patient (mean) 2.84  0.5 2.89  0.6 .2
BITA, Bilateral internal thoracic artery; LITA-RA, left internal thoracic artery–radial
artery; HTA, arterial hypertension; LVF, left ventricular function; MI, myocardial in-
farction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass
grafting; NYHA, New York Heart Association; euroSCORE, European System for
Cardiac Operative Risk Evaluation; IABP, intra-aortic balloon pump.
TABLE 2. Number of distal anastomosis for the different conduits and
types of graft combinations (non–left internal thoracic artery/left
anterior descending) performed
No. of distal anastomoses LITA RITA Radial
1 1483 187 101
2 215 987 147
3 277 5
Graft combinations
(non–LITA LAD) RITA Radial P value
Dg 464 (32%) 60 (23.7%) .01
Cx 965 (66.6%) 192 (75.8%)
Cx - Cx 403 (27.8%) 51 (20.1%) .06
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DRESULTS
Patient Characteristics in the Full Unmatched
Patient Population
Table 1 shows the preoperative characteristics of the full
unmatched study population. Patients in the BITA group
were more likely to be male and significantly younger
than patients receiving an RA as a concomitant second arte-
rial conduit (P< .0001). Patients in the LITA-RA group
were more frequently diabetic and had a higher European
System for Cardiac Operative Risk Evaluation (euro-
SCORE) than those in the BITA group (P ¼ .004 and
P ¼ .0001, respectively). The prevalence of patients with
impaired left ventricular function was higher in the
LITA-RA group (P ¼ .0001). Nonelective procedures
were significantly more frequent in the LITA-RA group,
but this difference was neutralized in the propensity
score–matched patient group. Other cardiovascular risk fac-
tors (eg, peripheral artery disease) or cerebrovascular mor-
bidities did not differ significantly between treatment
groups.RCA/PDA 883 (61.1%) 68 (26.8%) .0001
No. of target vessels/ patient (mean) 2.84  0.5 2.89  0.6 .2
Distal anastomosis/patient (mean) 3.0  0.6 2.7  0.6 <.001
LITA, Left internal thoracic artery; RITA, right internal thoracic artery; LAD, left an-
terior descending; Dg, diagonal; Cx, circumflex; RCA/PDA, right coronary artery/
posterior descending artery.Outcome in the Full Unmatched Patient Population
The mean number of distal anastomosis per patient was
3.1  0.6 in the BITA group and 2.7  0.5 in the
LITA-RA group (P<.001). No central (aortic) anastomoses634 The Journal of Thoracic and Cardiovascular Surgwere performed in any group of patients. Both RITA and
RA conduits were used as free grafts and anastomosed as
a T graft into the LITA bypass. The right coronary artery/
posterior descending artery coronary system received a sig-
nificantly higher number of bypasses with RITA than the
RA conduit: 883 (61.1%) versus 68 (26.8%) (P ¼ .0001).
After reviewing all of the clinical records and operative
notes, the right coronary artery/posterior descending artery
was not revascularized in more than 70% of the cases for
many reasons (diffuse disease, small diameter, no occlu-
sion, or no severe stenosis). There were no differences in
the number and types of bypasses performed for the diago-
nal and circumflex coronary systems between groups
(Table 2).
The intraoperative and postoperative outcome data of the
full unmatched patient population were evaluated. Skin-to-
skin time was longer in the BITA group than in the
LITA-RA group (199  38 minutes vs 188  43 minutes)
(P<.0001), and 91.5% of the patients in the BITA group
were extubated in the operative room versus 86% in the
LITA-RA group (P<.01).
In general, the LITA-RA group had a significantly worse
postoperative outcome than the BITA group: Respiratory
support more than 48 hours occurred in 17 patients
(6.7%) versus 32 patients (2.2%) (P ¼ .0001), low cardiac
output occurred in 17 patients (6.7%) versus 34 patients
(2.3%) (P¼ .001), stroke occurred in 4 patients (1.5%) ver-
sus 6 patients (0.4%) (P ¼ .04), and renal dysfunction oc-
curred in 12 patients (4.7%) versus 19 patients (1.3%)
(P<.001), respectively. Hospital mortality was higher in
the LITA-RA group than in the BITA group: 15 (5.9%) ver-
sus 20 (1.3%) (P ¼ .0001). Sternal wound infection with
a need for surgical intervention was not significantly differ-
ent between treatment groups (BITA 2.1% vs LITA-RA
1.4%, P ¼ .6).ery c February 2014
FIGURE 1. A, Survival after TAR OPCAB in the full unmatched
patient population: BITA (red line) versus LITA-RA (blue line); log-
rank: P ¼ .02. B, Postoperative readmission/reintervention-free survival
after TAR OPCAB in the full unmatched patient population. BITA (red
line) versus LITA-RA (blue line); log-rank: P ¼ .0001. C, Postoperative
combined end point–free survival (mortality plus reintervention/read-
mission) after TAR OPCAB in the full unmatched patient population:
BITA (red line) versus LITA-RA (blue line); log-rank: P < .0001.
BITA, Bilateral internal thoracic artery; LITA, left internal thoracic
artery; RA, radial artery.
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dictors for hospital mortality were age (odds ratio
[OR], 1.09; 95% confidence interval [CI], 1.02-1.13;
P< .0001), severe left ventricular dysfunction (OR, 2.5;
95% CI, 1.24-5.08; P < .01), and nonelective surgery
(OR, 10.3; 95% CI, 3.9-26.9; P ¼ .0001). The use of
BITAwas identified as protective for the incidence of major
complications (OR, 0.634; 95% CI, 0.41-0.96; P ¼ .03).
Follow-up of hospital survivors (n ¼ 1665) was 94.1%
complete (n ¼ 1568; BITA: 1341 and LITA-RA: 227 pa-
tients). Median follow-up of all patients was 1364.5 days
(IQR, 724-1984 days). Median follow-up of the BITA group
was 1283 days (IQR, 697-1861 days). Median follow-up of
the LITA-RA group was 2080 days (IQR, 1313-2587 days)
(P< .001). There was no difference in the proportion of
patients with completed follow-up: BITA 94% versus
LITA-RA 95.3% (P ¼ .39).
There were 99 (6.3%) late deaths during follow-up. Only
37 deaths (2.3%) were due to cardiac causes (BITA: 24 pa-
tients vs LITA-RA: 13 patients; P ¼ .08). Figure 1 shows
the postoperative patient outcomes at 1, 4, and 7 years for
the full unmatched patient population.
Postoperative survival was 99%, 94%, and 90% in the
BITA group and 97%, 91%, and 83% in the LITA-RA
group (log-rank: P ¼ .02) (Figure 1, A) (hazard ratio
[HR], 0.59; 95% CI, 0.38-0.92; P ¼ .021 in the BITA
group). Postoperative readmission/reintervention-free sur-
vival was 98%, 94%, and 85% in the BITA group and
94%, 85%, and 78% in the LITA-RA group (log-rank:
P ¼ .00001) (Figure 1, B) (HR, 0.42; 95% CI, 0.28-0.61;
P<.001 in the BITA group). Postoperative combined end
point–free survival (mortality plus reintervention/readmis-
sion) was 97%, 89%, and 66% in the BITA group and
92%, 77%, and 53% in the LITA-RA group (log-rank:
P ¼ .00001) (Figure 1, C) (HR, 0.47; 95% CI, 0.35-0.63;
P< .001 in the BITA group). Overall, the BITA group
had significantly better long-term outcomes than the
LITA-RA group.
Patient Characteristics in the Propensity
Score–Matched Patient Population
Table 3 shows the patient characteristics of the propensity
score–matched population. Because of the significantly
higher mean euroSCORE value in the LITA-RA group in
the full unmatched patient population, the propensity score
group turned out to be a high-risk group of patients, ex-
pressed by the high incidence of diabetesmellitus and severe
left ventricular dysfunction, and the number of nonelective
procedures. Postoperative cardiac-related deaths and com-
plicationswere not significantly different between treatment
groups. Hospital mortality was 4.03% in the BITA group
and 3.36% in the LITA-RA group (P ¼ .5). Perioperative
major complication rate was 10.7% in the BITA
group and 9.40% in the LITA-RA group (P ¼ .5).The Journal of Thoracic and Cardiovascular Surgery c Volume 147, Number 2 635
TABLE 3. Matched populations according to propensity variables and
number of patients in each quartile
BITA
(n ¼ 149)
LITA-RA
(n ¼ 149) P value
Age (y) 68  8.4 67  9.6 .81
Male (%) 82.5 81.2 .44
Diabetes mellitus (%) 30.8 32.2 .45
Severe LVF (%) 30.2 30.2 .55
euroSCORE (mean) 3.9  2.4 3.9  2.6 .49
Preoperative renal
dysfunction (%)
6.2 4.2 .44
Aortic calcification (%) 5.3 4.7 .5
Prior coronary surgery (%) 0.67 2.68 .18
Preoperative hematocrit (%) 39  4.4 39  5.8 .65
Nonelective surgery (%) 39.60 37.58 .42
3-vessel disease (%) 85.91 79.19 .085
No. of vessel disease 2.96 2.91 .76
Left main disease (%) 24.8 21.5 .49
First quartile (n) 96 96
Second quartile (n) 45 45
Third quartile (n) 7 7
Fourth quartile (n) 1 1
BITA, Bilateral internal thoracic artery; LITA-RA, left internal thoracic artery–radial
artery; LVF, left ventricular function; euroSCORE, European System for Cardiac
Operative Risk Evaluation.
FIGURE 2. A, Survival after TAR OPCAB in the propensity score–
matched patient population: BITA (red line) versus LITA-RA (blue line);
log-rank: P ¼ .65 B, Postoperative readmission/reintervention-free sur-
vival after TAR OPCAB in the propensity score–matched patient popula-
tion: BITA (red line) versus LITA-RA (blue line); log-rank: P ¼ .031.
C, Postoperative combined end point–free survival (mortality plus reinter-
vention/readmission) after TAR OPCAB in the propensity score–matched
patient population: BITA (red line) versus LITA-RA (blue line); log-rank:
P ¼ .038. BITA, Bilateral internal thoracic artery; LITA, left internal
thoracic artery; RA, radial artery.
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(BITA: 13 patients vs LITA-RA: 21 patients). Figure 2
shows the postoperative patient outcomes at 1, 4, and 7
years for the propensity score–matched group. Postopera-
tive survival at 1, 4, and 7 years was 97%, 93%, and
88%, respectively, in the BITA group and 98%, 92% and
83%, respectively, in the LITA-RA group (log-rank:
P ¼ .65) (Figure 2, A). Postoperative reintervention/
readmission-free survival at 1, 4, and 7 years was 97%,
94%, and 89%, respectively, in the BITA group and
97%, 85%, and 81%, respectively in the LITA-RA group
(log-rank: P¼ .031) (Figure 2,B). In multivariable analysis,
BITAwas the only independent predictor of reintervention/
readmission (HR, 0.40; 95% CI, 0.18-0.88; P ¼ .02). Post-
operative combined end points–free survival (mortality plus
reintervention/readmission) at 1, 4, and 7 years was 94%,
88%, and 80%, respectively, in the BITA group and
95%, 79%, and 66%, respectively, in the LITA-RA group
(log-rank: P ¼ .038) (Figure 2, C). In multivariable analy-
sis, BITA (HR, 0.54; 95% CI, 0.32-0.92; P ¼ .02) and
age in years (HR, 1.03; 95% CI, 1.004-1.06; P ¼ .02)
were independently associated with this combined
outcome.
Completeness of arterial revascularization was higher in
the BITA group than in the LITA-RA group (mean number
of distal anastomoses per patient 3.0  0.6 vs 2.7  0.6,
P<.001). There was a trend to higher relation grafts per-
formed/number of diseased vessels in the BITA group:
1.07 0.39 versus 0.99 0.39 (P¼ .08). However, neither636 The Journal of Thoracic and Cardiovascular Surgthe mean number of bypasses (HR, 0.88; 95% CI,
0.44-1.75; P ¼ .72) nor the relation grafts performed per
number of diseased vessels (HR, 0.70; 95% CI,ery c February 2014
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tors of higher incidence of reintervention/readmission rate.
Overall, in this propensity score–matched population, the
use of the RITA as a second arterial conduit in the BITA
group had a significantly superior reintervention/readmis-
sion and combined end points–free survival outcomes
than in the LITA-RA group.
DISCUSSION
The results of our study among 1700 patients provide ev-
idence for the superiority of a RITA graft compared with the
RA as a second conduit in TAR OPCAB and indicate that
the RA is not an equal alternative conduit to the RITA rel-
ative to both survival and cardiac-related morbidity. The
propensity score–matched approach showed significant ad-
vantages of the RITA procedure for the long-term outcome,
expressed by a significantly superior readmission/reinter-
vention and combined end points–free survival outcomes.
Basal clinical characteristics show that patients in the
LITA-RA group were a significantly higher-risk population
than the patients in the BITAgroup. Patients in the LITA-RA
groupwere older, weremore frequently female and diabetic,
had more severe left ventricular dysfunction, had a history
of NYHA class IV, and had a higher euroSCORE. Despite
all of these factors, the initial differences were neutralized
with the use of the propensity-score matched approach. In
the unmatched group of patients, the LITA-RA group had
significantly higher hospital mortality and major complica-
tions than the BITA group. The LITA-RA group represents
our initial TAROPCAB surgical experience, and some type
of learning curve effect might be one of the possible expla-
nations for these hospital results. The low incidence of
stroke in both groups almost certainly reflects no aortic ma-
nipulation when a second ITA and RA are used as T grafts
from the LITA. It is well known that aortic manipulation
carries a substantial risk for stroke.11 In the propensity
score–matched population, there was no difference in-
hospital mortality or the incidence of major complications.
Although the use of BITA has been considered a risk fac-
tor for sternal infection, especially in patients with diabetes,
reduction of wound complications has been reported when
the skeletonized technique is properly applied.12 In the
present study, all ITAs were harvested using the skeleton-
ized technique, and postoperative serum glucose was well
controlled. The incidence of deep sternal infection in our se-
ries was low, without a significant difference between
groups.
Themain reason for the long-termbenefit ofBITAgrafting
lies in the anatomic structure of the ITAs, which are less sus-
ceptible to atherosclerosis than RAs. The lower capacity of
nitric oxide release contributes to the susceptibility of the
RA to atherosclerosis and is therefore responsible for the
inferior long-term graft patency.13 Concerns about the long-
term patency of the RA that support our findings have beenThe Journal of Thoracic and Caraised by Ruttmann and colleagues4 and Khot and col-
leagues.5 In a multicenter randomized clinical trial
(Radial Artery Patency Study), Deb and colleagues14 demon-
strated a superior longitudinal angiographic patency rate of
the RA comparedwith SVGsmore than 5 years after surgery.
In a randomized and well-done study, Hayward and col-
leagues15 demonstrated a good patency rate of the RA at
a mean of 5.5 years angiographic follow-up control, without
any difference in patency between the free RITA and the
SVG. In the same study, the absolute survival (mean, 6.0
years) and event-free survival were equivalent between
groups (RITAvsRA). In a randomized studycomparing4 dif-
ferent surgical strategies, Nasso and colleagues16 concluded
that myocardial revascularization with 2 arterial conduits in
multivessel coronary disease offers better event-free survival
compared with a single arterial graft (LITA-LAD strategy),
irrespective of which conduit is used as a second-choice
arterial graft (RITAorRA)þSVG.Therewere several differ-
ences in these studies compared with our work15: An on-
pump technique was used; the rates of TAR were 30.3%
and 27.0% for the RA and RITA groups, respectively;
sequential graft configurations were not allowed in either of
the studies14,15; 1 or more supplementary vein grafts were
used; and proximal anastomoses were to the aorta, which
may explain the higher incidence of postoperative stroke. In
the latter study,16 therewas an inferiormean number of grafts
per patient performed to the aorta, with a relative short-term
follow-up (mean, 2 years). These differences make it impos-
sible to draw any definitive conclusions regarding the
equivalent performances of the 2 arterial conduits in the
long-term follow-up.
In our series of TAR OPCAB, patients in the LITA-RA
group had inferior reintervention/readmission and com-
bined end points–free survival outcomes than patients in
the BITA group. These surgical techniques have been
used by our group as routine procedures since 2002 and al-
low us to avoid performing the proximal anastomosis over
the ascending aorta and at the same time to obtain more
length of the arterial conduits used to perform sequential
anastomosis. With the use of this T-graft technique, double
sequential grafts to the circumflex coronary artery was fea-
sible in more than 25% of the cases.
The addition of off-pump techniques to this approach cre-
ates a more technically demanding procedure.8 OPCAB
offers superior postoperative outcomes with regard to
major cerebrovascular and cardiac complications9,17,18 and
disproportional benefits in high-risk patients.10The combina-
tion of an aortic, no-touch strategy with the TAR techniques
used in this series can effectively reduce neurologic compli-
cations while yielding excellent long-term outcomes.19-21
Furthermore, off-pump surgery has been repeatedly crit-
icized to come at a cost of less complete revascularization,
suggesting that it is not preferable in patients with multives-
sel disease.22-24 In our series, this surgical strategyrdiovascular Surgery c Volume 147, Number 2 637
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Dallowed us to perform a high rate of complete arterial
revascularizations in both groups of patients.Study Limitations
This is a retrospective study, and although the propensity
score–matching algorithm produced rather comparable
groups, the study was not randomized, and we cannot rule
out additional effects of missing covariates. In addition,
the study period was long and most of the LITA-RA off-
pump procedures were performed in the earlier part of the
study, and BITA experience comes later. Despite the use
of propensity score analysis, this issue may have played
a role in the final results. The longer follow-up of patients
in the LITA-RA group compared with the BITA group is
a further limitation for the interpretation of the findings.
However, despite the shorter follow-up, there is a clear dif-
ference in long-term outcomes supporting a benefit of using
the RITA as a second arterial graft.CONCLUSIONS
In view of our study results, the second ITA graft should
be used more frequently for CABG in the future. The use of
the RITA may extend the benefits of TAR to a larger popu-
lation undergoing OPCAB surgery, producing better long-
term results even though the initial operation is longer
and technically more demanding.References
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